In summary, our current findings demonstrate a novel role for RHBDD1 in promoting tumor cell growth through the ADAM-independent cleavage and secretion of proTGFα to activate the EGFR/Raf/MEK/ERK signalling pathway in CRC. The gene discussed is RHBDD1; the disease is neoplasm.